Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Abnormal ECM and immune cell interactions can cause skin diseases.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Lacrimal gland inflammation and alopecia areata can happen together due to autoimmune issues.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Some drugs used to treat inflammation may cause hair loss.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Some drugs used to treat immune conditions may cause different types of hair loss.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Alarmin cytokines are key in controlling skin immunity and inflammation.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.